Department News

The Office of Research and Graduate Education conducted its fifth annual white coat ceremony to recognize 19 students from the Class of 2020-2021 — 15 students in the PhD Program in Biomedical Sciences (PPBS) and four MD-PhD students — who are matching to their doctoral laboratories.

Jacobs School of Medicine and Biomedical Sciences scientists who are doing genomic sequencing of COVID-19 samples report that the delta variant of the coronavirus has been detected in Erie County.

Locally and nationwide, the number of COVID-19 cases is plummeting and the predominant message seems to be that the worst of the pandemic may be behind us.

An expert on neuropsychology and mutliple sclerosis and others who have made significant contributions to their fields and to the Jacobs School of Medicine and Biomedical Sciences were honored with 2021 Faculty-Staff Recognition Awards.

Thirty-three doctoral, 61 master’s and 184 baccalaureate candidates were eligible to receive degrees in biomedical science fields during the May commencement ceremony.

Research by M. Laura Feltri, MD, that seeks to design and develop a therapy for multiple sclerosis (MS) — leveraging a novel drug target discovered by Feltri’s team — has received a $250,000 investment from the Empire Discovery Institute (EDI).

As highlighted in a recent UBNow story, researchers and teams from UB’s Clinical and Translational Science Institute that previously implemented elements of team science in their work were far better prepared to navigate the changes wrought by COVID-19 than those that did not.

Fifteen students in the Jacobs School of Medicine and Biomedical Sciences were honored for outstanding achievements at the University at Buffalo’s 2021 Celebration of Student Academic Excellence.

A pair of research studies led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, reveal important new findings as to how regeneration of myelin in multiple sclerosis (MS) fails and, potentially, more efficient ways to treat it.

Researchers from the Jacobs School of Medicine and Biomedical Sciences have found evidence of the so-called California variants of COVID-19 — B.1.427 and B.1.429 — in virus samples of Western New Yorkers who tested positive in January by using genetic sequencing to decode the genes of SARS-CoV-2 and better understand how it is evolving.

The research projects, from 48 aspiring physician-scientists, were presented at the 2021 Virtual Medical Student Research Forum.

Students and laboratories affiliated with the Genetics, Genomics and Bioinformatics graduate program (GGB) shared their findings during the seventh annual GGB Research Day.

Research by Gabriela K. Popescu, PhD, professor of biochemistry, has revealed that the absence of a single interaction within a brain receptor reduces its activity. The discovery advances the understanding of how certain brain diseases arise, and could lead to developing precision medicines for treating them.

Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a computational approach to make drug discovery faster and less expensive while also being safe and effective.